Pharmaceutics News
-
Veteran Sales And Business Leader Christian Ahlmark Joins Pharmaceutics International, Inc. (Pii) As Vice President Of Sales And Business Development
5/12/2022
In his new role, Christian will be responsible for leading his team in supporting Pii’s broad CDMO capabilities in oral drug and parenteral development.
-
Roberto Almodóvar Febles Joins Pii As Head Of Aseptic Operations
8/31/2021
Roberto Almodóvar Febles will oversee and manage day-to-day aseptic manufacturing and work closely with Sam Chia, the Head of Aseptic Manufacturing Science and Technology (MS&T) and the Operations Leadership Team (OLT) members.
-
Pharmaceutics International, Inc. (Pii) To Platform West Pharmaceutical Services, Inc.’s Daikyo Crystal Zenith® Container-Closure Components For Aseptic Fill-Finish
8/4/2021
Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO), will include Daikyo Crystal Zenith® (CZ) container-closure components, offered by West Pharmaceutical Services, Inc. (West), as part of its aseptic fill-finish capabilities across vials, syringes and cartridges.
-
Monique Mendoza Promoted To Head Of Quality At Pharmaceutics International, Inc. (Pii)
2/22/2021
In her new, promoted role, Ms. Mendoza will be responsible for the entire Quality unit. Her scope of responsibilities includes: Sterility Assurance, Batch Disposition, Investigations, Change Controls, Product Complaints, Supplier Qualification, Raw Material Release, Audits (internal, external and client), Document Control, and Quality Control across all facilities including Microbiology Laboratories.
-
Humanetics Corporation And Pharmaceutics International, Inc. Announce Partnership In Support Of BIO 300 Clinical Trials In COVID-19 Patients
8/20/2020
Hunt Valley, MD - Humanetics Corporation and Pharmaceutics International, Inc. (Pii) will work together to support a clinical trial of BIO 300 in COVID-19 patients.
-
Pii Is Offering A $100,000 Grant For A First-In-Human Project
8/5/2020
The pharmaceutical industry appears to be experiencing a shift in resources to more urgent, immediate needs related to the pandemic, leaving emerging biotech companies short on resources to even get through the remainder of the year. At Pii we know that your scaled back projects are more than projects. They are promising therapies and somewhere a patient has planned for your success. That is the reason for this grant!
-
Pharmaceutics International, Inc. (Pii) – A Key Part Of The FDA’s 503B Solution
7/2/2020
Pharmaceutics International, Inc. (Pii) has been added to the FDA’s list of organizations officially registered as human drug outsourcing facilities under the updated requirements of Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
-
Pharmaceutics International, Inc. (Pii) Announces The Expansion Of Its Commercial Team
7/1/2019
Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) headquartered in Hunt Valley, Maryland, is pleased to announce the expansion of its commercial team with the additions of Wayne Ideus, Wayne Grellner and Ryan McFarlane.